Skip to content Skip to footer

A Week in Review: Navigating the Infection Prevention Landscape – Top Stories from Infection Control Today

In the rapidly evolving field of infection control, professionals can occasionally find themselves lost amidst the flurry of new information. This comprehensive review aims to highlight the important takeaways from Infection Control Today’s coverage for the week ending on March 10, 2024. The objective is to equip infection preventionists and other healthcare professionals with the key insights they need in their practice, spanning from invaluable interviews with thought leaders to news that directly impacts their role.

We will begin by exploring the Product Locator feature where the spotlight is cast on the latest advancements in technology for infection prevention. This week’s highlights include Therawork Protect and the AMSCO Prep & Pack Table, both of which promise to redefine the dynamics of handling risk and improve preventative measures.

Now, let’s delve into a thought-provoking piece discussing the implications of antimicrobial resistance through a global-to-local health perspective. This article showcases the irreplaceable role infection preventionists play in the fight against multidrug-resistant organisms. It underscores the obstacles of treatment and the constantly evolving challenges posed by antimicrobial resistance. The discussion with Katharine J. Hoffman, MPH, CIC provides firsthand knowledge and expertise on the matter.

Further, the complex world of prions is unraveled in a succinct guide designed for healthcare workers. The insights provided by Ryan A. Maddox, Ph.D., from the CDC come to the forefront, lending clarity to handling these rare proteins and their associated risks.

Next on the list, a worrying update on measles cases reflects a significant issue. With ten cases reported in Florida alone, questions arise about the origins of this resurgence, the cause behind the soaring transmission rates, and if herd immunity is steadily diminishing.

The week’s coverage also brings a Q&A session with Lorraine Ash, MA, the editor of ‘Corona City: Voices From an Epicenter.’ This anthology captures the raw, unfiltered narratives that emerged during the COVID-19 pandemic, offering a poignant and diverse understanding of the crisis. The discussion unveils the challenges of creating this anthology and its profound impact on the readers and communities worldwide.

Finally, Infection Control Today discusses recent findings from Pfizer Inc’s Phase 3 clinical trial. The data reveals that the Abrysvo vaccine demonstrates stellar efficacy against respiratory syncytial virus (RSV) in adults aged 60 and older. Such findings bear substantial implications for anyone working in infection control, especially when it comes to combating RSV infections in susceptible populations.


Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]